Following a decade of successfully shaping market leaders across the rapidly evolving animal health market,
Vimian and its family of companies cover four essential areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and
“By establishing Vimian, we are creating a global platform with a clear ambition to lead the ongoing transformation of the animal health market. With Vimian, we are bringing together some of the most innovative, high-quality and entrepreneurial businesses under one umbrella, to create a uniquely diversified proposition of products and services across four high-growth animal health verticals”, says
The first building block of Vimian was laid in 2015, when Fidelio invested in what was to become Nextmune, Vimian’s Specialty Pharma division. Since then, Fidelio has continued to partner with entrepreneurs, management teams and owners of market leading businesses within Diagnostics (Indical Bioscience), Veterinary Services (VetFamily) and
“With Vimian, we combine the strengths and capabilities of a global group with the intimacy, speed and creativity of an owner-led business. By sharing knowledge, insights and resources across our family of businesses, we create an unmatched opportunity to accelerate innovation, talent acquisition and growth. Together, we are able to reach over 15,000 veterinary clinics and 1,500 labs globally, with exceptional science and technology throughout our four areas. We all share a passion for making a positive impact through improving animal health, and I look forward to an exciting journey ahead with the entire Vimian team”, says Dr.
For further information, please contact:
Email: gabriel.fitzgerald@fideliocapital.se / Mobile: +46 70 635 29 29
Email: fredrik.ullman@vimian.com / Mobile: +41 79 580 80 60
© Modular Finance, source